venlafaxine hydrochloride has been researched along with Cardiovascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kallikazaros, IE; Katsi, VK; Makris, T; Marketou, M; Stefanadis, CI; Tousoulis, D; Vamvakou, G; Vardas, P | 1 |
| Boerstoel-Streefland, M; Duh, MS; Guérin, A; Jiang, W; Lefebvre, P; Mease, PJ; Vekeman, F; Zimetbaum, PJ | 1 |
| Seeger, J; Strombom, I; Turnbull, B; Xue, F; Zhu, S | 1 |
| Begley, AE; Johnson, EM; Mulsant, BH; Pollock, BG; Reynolds, CF; Weber, E; Whyte, E | 1 |
| Brilmyer, M; Kant, R; Zeiler, D; Zimmer, B | 1 |
1 review(s) available for venlafaxine hydrochloride and Cardiovascular Diseases
| Article | Year |
|---|---|
Novel antidepressant drugs, arterial hypertension and cardiovascular disease.
Topics: Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Cardiovascular System; Cyclohexanols; Humans; Hypertension; Patents as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
1 trial(s) available for venlafaxine hydrochloride and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.
Topics: Age of Onset; Aged; Arrhythmias, Cardiac; Cardiovascular Diseases; Cognition Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Monitoring; Electrocardiography; Female; Guidelines as Topic; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Male; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tachycardia; Venlafaxine Hydrochloride | 2006 |
3 other study(ies) available for venlafaxine hydrochloride and Cardiovascular Diseases
| Article | Year |
|---|---|
Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data.
Topics: Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Antidepressive Agents; Cardiovascular Diseases; Cyclopropanes; Female; Heart Failure; Humans; Male; Middle Aged; Milnacipran; Myocardial Infarction; Retrospective Studies; Risk; Selective Serotonin Reuptake Inhibitors; Stroke; United States; Venlafaxine Hydrochloride | 2011 |
Treatment with duloxetine in adults and the incidence of cardiovascular events.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Case-Control Studies; Cause of Death; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Electrocardiography; Female; Follow-Up Studies; Humans; Insurance Claim Review; Male; Propensity Score; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |
Antidepressant efficacy and cardiovascular safety of venlafaxine in young vs old patients with comorbid medical disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Mood Disorders; Risk Factors; Venlafaxine Hydrochloride | 1997 |